 |
Department of Social Sciences & Health Policy
Division of Public Health Sciences
Wake Forest University Health Sciences
Admin Assistant/Secretary: Susan Harris
Piedmont Plaza II (PLAZ2)
Room Number: 272
Telephone: 336-716-4289
Email: NMPKING@WFUBMC.EDU |
EDUCATION: |
JD with honors, UNC School of Law, 1980,
BA Magna cum Laude, St. John’s College, Annapolis, MD, 1975;
Download Curriculum Vitae (PDF) >>
|
RESEARCH: |
| Professor King joined the SSHP faculty in 2007, after nearly 20 years on the faculty of the School of
Medicine, UNC-Chapel Hill. She has written and taught extensively on issues related to informed
consent in health care and research, medical decisions at the beginning and end of life, the
development and use of experimental technologies, and international and cross-cultural questions in
human subjects research. A revised edition of her book, Making Sense of Advance Directives, was
published by Georgetown University Press in 1996. She is co-editor of The Social Medicine Reader (2nd
ed., Duke University Press, 2005) and Beyond Regulations: Ethics in Human Subjects Research (UNC
Press 1999). Her current scholarly foci include large- sample genetic research and biobanking, ethical
issues in the design of clinical trials, and benefit and uncertainty in human subjects research. She has
served on hospital ethics committees, IRBs, and DSMBs, and was a member of the Recombinant DNA
Advisory Committee of NIH from 1998-2002. In 2002 she was elected a Fellow of the Hastings Center.
Professor King directs WFU’s Research Ethics Consultation Program and serves on the School of
Medicine’s SIRE Committee and the iDSMB. She has cross-appointments in the Department of Internal
Medicine, the Wake Forest Institute for Regenerative Medicine, and the Translational Science Institute.
She also works with colleagues on both the Reynolda and Bowman Gray campuses to develop WFU’s
Center for Bioethics, Health, and Society and the Master of Arts in Bioethics degree program. |
PUBLICATIONS (10 most recent):
View all publications for this profile>>
|
Easter MM;Henderson GE;Davis AM;Churchill LR;King NM; The many meanings of care in clinical research; Sociol Health Illn ; 2006 Sep; 28:695-712
|
|
Kipnis K;King NM;Nelson RM; An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial; Am J Bioeth ; 2006 May; 6:18-21
|
|
Kipnis K;King NM;Nelson RM; Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver; IRB ; 2006 Mar; 28:16-19
|
|
Henderson GE;Easter MM;Zimmer C;King NM;Davis AM;Rothschild BB;Churchill LR;Wilfond BS;Nelson DK; Therapeutic misconception in early phase gene transfer trials; Soc Sci Med ; 2006 Jan; 62:239-253
|
|
King NM;Henderson GE;Churchill LR;Davis AM;Hull SC;Nelson DK;Parham-Vetter PC;Rothschild BB;Easter MM;Wilfond BS; Consent forms and the therapeutic misconception: the example of gene transfer research; IRB ; 2005 Jan; 27:1-8
|
|
Henderson GE;Davis AM;King NM;Easter MM;Zimmer CR;Rothschild BB;Wilfond BS;Nelson DK;Churchill LR; Uncertain benefit: investigators' views and communications in early phase gene transfer trials; Mol Ther ; 2004 Aug; 10:225-231
|
|
Henderson GE;Davis AM;King NM; Vulnerability to influence: a two-way street; Am J Bioeth ; 2004; 4:50-52
|
|
Churchill LR;Nelson DK;Henderson GE;King NM;Davis AM;Leahey E;Wilfond BS; Assessing benefits in clinical research: why diversity in benefit assessment can be risky; IRB ; 2003 May; 25:1-8
|
|
King NM; Accident & desire. Inadvertent germline effects in clinical research; Hastings Cent Rep ; 2003 Mar; 33:23-30
|
|
King NM; The line between clinical innovation and human experimentation; Seton Hall Law Rev ; 2003; 32:571-580
|
|
 How to update your website profile and publications >> |
